hdm2005
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 12, 2024 (NCT06615193)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07124936 | Phase 1/Phase 2 (Phase 2) | Jul 30, 2025 | Hangzhou Zhongmei |
| NCT07004296 | Phase 1 | May 29, 2025 | Hangzhou Zhongmei |
| NCT06615193 | Phase 1 | Aug 12, 2024 | Hangzhou Zhongmei |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hangzhou Zhongmei | For profit | 3 | 3 | 2 | 2024 |
1 organizations
Page 1 / 1